Company / Current Assets
BioRestorative Therapies, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$3.1M
FY2025
5-year range
$3.1M / $21.5M
FY2021-FY2025
Trend
-71.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has declined for 4 consecutive years, from $21M in FY2021 to $3M in FY2025.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of -0.3%.
Declined from $11M to $3M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -40.8%
- 5-Year CAGR
- -0.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- BioRestorative Therapies, Inc.'s current assets has declined for 4 consecutive years.
- 5-year CAGR of -0.3%, indicating a declining trend.
- In FY2025, current assets decreased 71.9% year-over-year.
- Peak current assets was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -47.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.1M | -71.9% |
| FY2024 | $11.1M | -2.2% |
| FY2023 | $11.4M | -24.7% |
| FY2022 | $15.1M | -29.5% |
| FY2021 | $21.5M | +573.6% |
| FY2020 | $3.2M | +4528.1% |
| FY2019 | $68.9K | -62.0% |
| FY2018 | $181.0K | -65.2% |
| FY2017 | $519.7K | +742.6% |
| FY2016 | $61.7K | -78.7% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026